SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-069608
Filing Date
2024-06-07
Accepted
2024-06-07 16:00:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2416749d3_defa14a.htm DEFA14A 10326
2 GRAPHIC tm2416749d3_defa14aimg001.jpg GRAPHIC 9617
  Complete submission text file 0001104659-24-069608.txt   24763
Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Filer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40363 | Film No.: 241029154
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)